SC
GSK icon

Syon Capital’s GSK GSK Stock Holding History

Syon Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.55M Buy
29,588
+117
+0.4% +$6.19K 0.07% 213
2026
Q1 		$1.63M Buy
29,471
+398
+1% +$21.6K 0.08% 183
2025
Q4 		$1.43M Buy
29,073
+382
+1% +$17.8K 0.07% 203
2025
Q3 		$1.24M Buy
28,691
+1,267
+5% +$49.5K 0.07% 205
2025
Q2 		$1.05M Buy
27,424
+684
+3% +$26.1K 0.07% 201
2025
Q1 		$1.04M Buy
26,740
+1,078
+4% +$39.5K 0.08% 176
2024
Q4 		$868K Sell
25,662
-7,652
-23% -$275K 0.08% 179
2024
Q3 		$1.36M Sell
33,314
-902
-3% -$36.9K 0.12% 130
2024
Q2 		$1.32M Sell
34,216
-1,072
-3% -$45.1K 0.12% 125
2024
Q1 		$1.51M Buy
35,288
+601
+2% +$24.8K 0.14% 107
2023
Q4 		$1.29M Buy
34,687
+7,116
+26% +$255K 0.13% 114
2023
Q3 		$999K Buy
+27,571
New +$979K 0.12% 105

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Syon Capital's GSK Position: Q2 2026 in Review

Syon Capital increased its GSK (GSK) stake by 0.4% in Q2 2026, buying an estimated $6.19K and bringing the position to 29,588 shares worth $1.55M. The position accounts for 0.07% of the portfolio, ranked #213.

Syon Capital first reported a position in GSK in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.63M in Q1 2026. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Syon Capital held 29,588 shares of GSK worth $1.55M as of Q2 2026.
  • Syon Capital bought 117 GSK shares in Q2 2026, an estimated $6.19K.
  • GSK made up 0.07% of Syon Capital's portfolio in Q2 2026, its #213 holding.
  • Syon Capital first reported a position in GSK in Q3 2023 and has held it in 12 quarters since.
  • Syon Capital's GSK position peaked at $1.63M in Q1 2026.
  • 1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.